Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Patients with early stage of cervical cancer when treated with surgery or radiotherapy are likely to have a good analysis. However, besides good analysis treatment failure still occurs and about 30% of the patients treated for cervical carcinoma develop advanced or repeated tumours. Patients who suffer recurrence have a miserable prognosis with a 1-year survival rate of between 15 and 20% Recurrent cervical cancer is defined as local tumour re-growth or the development of nodal or distant metastases at least 6 months after the injury has relapsed. Outstanding disease is that which is evident within 6 months of primary treatment. Risk factors for recurrence of cervical carcinoma include the histological type, size, depth of stromal invasion, and the nodal status at presentation.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi